Reversible posterior leukoencephalopathy syndrome following R-CHOP therapy for diffuse large B-cell lymphoma

MeSH terms

• Adult
• Antibodies, Monoclonal / adverse effects
• Antibodies, Monoclonal / therapeutic use
• Antibodies, Monoclonal, Murine-Derived
• Antineoplastic Agents / adverse effects
• Antineoplastic Agents / therapeutic use
• Antineoplastic Combined Chemotherapy Protocols / adverse effects*
• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Cyclophosphamide / adverse effects
• Cyclophosphamide / therapeutic use
• Doxorubicin / adverse effects
• Doxorubicin / therapeutic use
• Female
• Humans
• Lymphoma, Large B-Cell, Diffuse / drug therapy*
• Magnetic Resonance Imaging
• Posterior Leukoencephalopathy Syndrome / chemically induced*
• Posterior Leukoencephalopathy Syndrome / diagnosis*
• Posterior Leukoencephalopathy Syndrome / pathology
• Prednisolone / adverse effects
• Prednisolone / therapeutic use
• Prednisone / adverse effects
• Prednisone / therapeutic use
• Rituximab
• Vincristine / adverse effects
• Vincristine / therapeutic use